Cormorant Global Healthcare Master Fund, LP, Insider at MoonLake Immunotherapeutics (MLTX), sold 9,961,669 shares at $8.40 ($73.2M) on 2025-09-29, disclosed to the SEC on 2025-10-01.
Open-market sale of $73.2M MLTX by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.61 | 2,800,000 | $18.5M | 25.3% |
| 2 | $7.58 | 3,390,943 | $25.7M | 35.1% |
| 3 | $7.58 | 3,390,943 | $25.7M | 35.1% |
| 4 | $8.40 | 232,460 | $2.0M | 2.7% |
| 5 | $9.38 | 70,748 | $664K | 0.9% |
| 6 | $9.38 | 70,748 |
| $664K |
| 0.9% |
| 7 | $6.96 | 5,827 | $41K | 0.1% |
| Total | $7.35 avg | 9,961,669 | $73.2M | 100% |
| Filing → |
| CRBP | BUY | 2024-09-24 | $14.0M | — | Filing → |
| EYPT | BUY | 2024-04-22 | $21.0M | — | Filing → |
| IMRX | SELL | 2024-03-18 | $4.6M | — | Filing → |